These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

786 related items for PubMed ID: 31521440

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.
    Savarese G, Vedin O, D'Amario D, Uijl A, Dahlström U, Rosano G, Lam CSP, Lund LH.
    JACC Heart Fail; 2019 Apr; 7(4):306-317. PubMed ID: 30852236
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A comprehensive population-based characterization of heart failure with mid-range ejection fraction.
    Koh AS, Tay WT, Teng THK, Vedin O, Benson L, Dahlstrom U, Savarese G, Lam CSP, Lund LH.
    Eur J Heart Fail; 2017 Dec; 19(12):1624-1634. PubMed ID: 28948683
    [Abstract] [Full Text] [Related]

  • 5. Atrial Fibrillation in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Sartipy U, Dahlström U, Fu M, Lund LH.
    JACC Heart Fail; 2017 Aug; 5(8):565-574. PubMed ID: 28711451
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Different relationships between pulse pressure and mortality in heart failure with reduced, mid-range and preserved ejection fraction.
    Teng TK, Tay WT, Dahlstrom U, Benson L, Lam CSP, Lund LH.
    Int J Cardiol; 2018 Mar 01; 254():203-209. PubMed ID: 29407092
    [Abstract] [Full Text] [Related]

  • 8. Associations with and prognostic impact of chronic kidney disease in heart failure with preserved, mid-range, and reduced ejection fraction.
    Löfman I, Szummer K, Dahlström U, Jernberg T, Lund LH.
    Eur J Heart Fail; 2017 Dec 01; 19(12):1606-1614. PubMed ID: 28371075
    [Abstract] [Full Text] [Related]

  • 9. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
    Vedin O, Lam CSP, Koh AS, Benson L, Teng THK, Tay WT, Braun OÖ, Savarese G, Dahlström U, Lund LH.
    Circ Heart Fail; 2017 Jun 01; 10(6):. PubMed ID: 28615366
    [Abstract] [Full Text] [Related]

  • 10. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T, Suzuki A, Haruta S, Mori F, Ota Y, Yagi M, Oka T, Tanaka H, Murasaki S, Yamauchi T, Katoh J, Hattori H, Kikuchi N, Watanabe E, Yamada Y, Haruki S, Kogure T, Suzuki T, Uetsuka Y, Hagiwara N, HIJ-HF II Investigators.
    ESC Heart Fail; 2019 Jun 01; 6(3):475-486. PubMed ID: 30829002
    [Abstract] [Full Text] [Related]

  • 11. Incidence, Predictors, and Outcome Associations of Dyskalemia in Heart Failure With Preserved, Mid-Range, and Reduced Ejection Fraction.
    Savarese G, Xu H, Trevisan M, Dahlström U, Rossignol P, Pitt B, Lund LH, Carrero JJ.
    JACC Heart Fail; 2019 Jan 01; 7(1):65-76. PubMed ID: 30553905
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G, Ghionzoli N, Innocenti L, Taddei C, Giannoni A, Valleggi A, Borrelli C, Senni M, Passino C, Emdin M.
    J Am Heart Assoc; 2019 Oct 15; 8(20):e013441. PubMed ID: 31587602
    [Abstract] [Full Text] [Related]

  • 14. Clinical characteristics and prognosis of heart failure with mid-range ejection fraction: insights from a multi-centre registry study in China.
    Lyu S, Yu L, Tan H, Liu S, Liu X, Guo X, Zhu J.
    BMC Cardiovasc Disord; 2019 Sep 02; 19(1):209. PubMed ID: 31477021
    [Abstract] [Full Text] [Related]

  • 15. Age-dependent differences in clinical phenotype and prognosis in heart failure with mid-range ejection compared with heart failure with reduced or preserved ejection fraction.
    Chen X, Savarese G, Dahlström U, Lund LH, Fu M.
    Clin Res Cardiol; 2019 Dec 02; 108(12):1394-1405. PubMed ID: 30980205
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-B-type natriuretic peptide in chronic heart failure: The impact of sex across the ejection fraction spectrum.
    Faxén UL, Lund LH, Orsini N, Strömberg A, Andersson DC, Linde C, Dahlström U, Savarese G.
    Int J Cardiol; 2019 Jul 15; 287():66-72. PubMed ID: 31005415
    [Abstract] [Full Text] [Related]

  • 17. Predictors and outcomes of heart failure with mid-range ejection fraction.
    Bhambhani V, Kizer JR, Lima JAC, van der Harst P, Bahrami H, Nayor M, de Filippi CR, Enserro D, Blaha MJ, Cushman M, Wang TJ, Gansevoort RT, Fox CS, Gaggin HK, Kop WJ, Liu K, Vasan RS, Psaty BM, Lee DS, Brouwers FP, Hillege HL, Bartz TM, Benjamin EJ, Chan C, Allison M, Gardin JM, Januzzi JL, Levy D, Herrington DM, van Gilst WH, Bertoni AG, Larson MG, de Boer RA, Gottdiener JS, Shah SJ, Ho JE.
    Eur J Heart Fail; 2018 Apr 15; 20(4):651-659. PubMed ID: 29226491
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.
    Chioncel O, Lainscak M, Seferovic PM, Anker SD, Crespo-Leiro MG, Harjola VP, Parissis J, Laroche C, Piepoli MF, Fonseca C, Mebazaa A, Lund L, Ambrosio GA, Coats AJ, Ferrari R, Ruschitzka F, Maggioni AP, Filippatos G.
    Eur J Heart Fail; 2017 Dec 15; 19(12):1574-1585. PubMed ID: 28386917
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.